Fredrik Ullman
Chief Executive Officer en Indical Bioscience GmbH .
Fortuna: 11 M $ al 31/03/2024
Perfil
Fredrik Ullman ocupa el cargo de Director General de Vimian Group AB.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
VIMIAN GROUP AB
0.47% | 31/12/2022 | 2 388 414 ( 0.47% ) | 7 M $ | 31/03/2024 |
VIMIAN GROUP AB
8.25% | 31/12/2022 | 1 214 554 ( 8.25% ) | 4 M $ | 31/03/2024 |
Cargos activos de Fredrik Ullman
Empresas | Cargo | Inicio |
---|---|---|
Innoverse GmbH | Corporate Officer/Principal | - |
Indical Bioscience GmbH
Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany. | Chief Executive Officer | - |
Antiguos cargos conocidos de Fredrik Ullman.
Empresas | Cargo | Fin |
---|---|---|
VIMIAN GROUP AB | Chief Executive Officer | 01/01/2024 |
Formación de Fredrik Ullman.
Royal Institute of Technology | Graduate Degree |
Swiss Federal Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
VIMIAN GROUP AB | Health Technology |
Empresas privadas | 2 |
---|---|
Indical Bioscience GmbH
Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany. | Commercial Services |
Innoverse GmbH |
- Bolsa de valores
- Insiders
- Fredrik Ullman